Literature DB >> 22297074

A review of the association between osteosarcoma metastasis and protein translation.

T S Osborne1, C Khanna.   

Abstract

The malignant transformation of mesenchymal cells within the bone leads to the development of osteosarcoma (OS), but the genetic underpinnings of these events are not understood. From a clinical perspective, primary tumour management can be achieved successfully in most patients. However, the development of metastasis to the lungs represents the most common cause of death in OS patients. A clearer understanding of metastasis biology is required to improve cancer mortality and improve outcomes. Modelling the genetics, biology and therapy of OS can be accomplished through research involving a number of species. Most notable is the naturally occurring form of OS that develops in dogs. Through a cross-species and comparative approach important questions can be asked within specific and suitable models to advance our understanding of this disease and its common metastatic outcome. A comparative perspective on the problem of OS metastasis that utilizes a cross-species approach may offer unique opportunities to assist in this prioritization and generate new hypotheses related to this important clinical problem. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22297074      PMCID: PMC3496179          DOI: 10.1016/j.jcpa.2011.12.007

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  84 in total

Review 1.  The cell cycle: myths and realities.

Authors:  R Baserga
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

2.  Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.

Authors:  H J Berkel; E A Turbat-Herrera; R Shi; A de Benedetti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-06       Impact factor: 4.254

Review 3.  Mechanism of action and regulation of protein synthesis initiation factor 4E: effects on mRNA discrimination, cellular growth rate, and oncogenesis.

Authors:  R E Rhoads; S Joshi-Barve; C Rinker-Schaeffer
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1993

Review 4.  Cross talk from pets to people: translational osteosarcoma treatments.

Authors:  Stephen J Withrow; Ross M Wilkins
Journal:  ILAR J       Date:  2010

5.  Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.

Authors:  Nobuhiko Seki; Tasaburo Takasu; Koichi Mandai; Masao Nakata; Hideyuki Saeki; Yuji Heike; Ichiro Takata; Yoshihiko Segawa; Toshiaki Hanafusa; Kenji Eguchi
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

6.  Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line.

Authors:  R J DeFatta; C A Nathan; A De Benedetti
Journal:  Laryngoscope       Date:  2000-06       Impact factor: 3.325

7.  Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer.

Authors:  C A Nathan; L Liu; B D Li; F W Abreo; I Nandy; A De Benedetti
Journal:  Oncogene       Date:  1997-07-31       Impact factor: 9.867

Review 8.  Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells.

Authors:  Dennis W Stacey
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

9.  Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement.

Authors:  A G Huvos; G Rosen; R C Marcove
Journal:  Arch Pathol Lab Med       Date:  1977-01       Impact factor: 5.534

10.  High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions.

Authors:  Gaetano Bacci; Michele Rocca; Mariacristina Salone; Alba Balladelli; Stefano Ferrari; Emanuela Palmerini; Cristiana Forni; Antonio Briccoli
Journal:  J Surg Oncol       Date:  2008-11-01       Impact factor: 3.454

View more
  32 in total

1.  Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.

Authors:  Shibing Guo; Rui Bai; Wei Zhao; Yuxin Wang; Zhenqun Zhao; Wei Feng
Journal:  Tumour Biol       Date:  2014-01

2.  Over-expression of Sox4 and β-catenin is associated with a less favorable prognosis of osteosarcoma.

Authors:  Zheng-Qi Bao; Chang-Chun Zhang; Yu-Zhou Xiao; Jian-Sheng Zhou; Yi-Sheng Tao; Da-Min Chai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13

3.  Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.

Authors:  Yisila Mu; Haoshaqiang Zhang; Lixin Che; Kun Li
Journal:  Med Oncol       Date:  2013-12-19       Impact factor: 3.064

Review 4.  MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.

Authors:  Jinglei Miao; Song Wu; Zhi Peng; Mousumi Tania; Chaoyue Zhang
Journal:  Tumour Biol       Date:  2013-08

5.  Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies.

Authors:  Yu Liu; Yun-Hong Ma; Zhen-Zhong Sun; Yong-Jun Rui; Qu-Dong Yin; Sheng Song; Xu-Ming Wei; Jun Liu; Xue-Guang Liu; Ke-Jia Hu
Journal:  Tumour Biol       Date:  2014-06-05

6.  Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.

Authors:  Xiaoyang Wen; Hui Liu; Kailong Yu; Yang Liu
Journal:  Tumour Biol       Date:  2013-09-15

7.  Effect of miR-143 on the apoptosis of osteosarcoma cells.

Authors:  Hao Liu; Hongliang Wang; Haichun Liu; Yunzhen Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 8.  Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis.

Authors:  Yunyuan Zhang; Chunming Ding; Jing Wang; Guirong Sun; Yongxian Cao; Longqiang Xu; Lan Zhou; Xian Chen
Journal:  J Orthop Surg Res       Date:  2015-12-23       Impact factor: 2.359

9.  Anti-Metastatic and Anti-Angiogenic Effects of Curcumin Analog DK1 on Human Osteosarcoma Cells In Vitro.

Authors:  Muhammad Nazirul Mubin Aziz; Nurul Fattin Che Rahim; Yazmin Hussin; Swee Keong Yeap; Mas Jaffri Masarudin; Nurul Elyani Mohamad; Muhammad Nadeem Akhtar; Mohd Azuraidi Osman; Yoke Kqueen Cheah; Noorjahan Banu Alitheen
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-03

10.  Gene delivery in a mouse xenograft of a retargeted retrovirus to a solid 143B osteosarcoma.

Authors:  Xia Zhang; Anindita Sarangi; Dai-Tze Wu; Jaya Kanduri; Monica J Roth
Journal:  Virol J       Date:  2013-06-14       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.